...
首页> 外文期刊>Journal of Clinical Microbiology >Serological Monitoring of Progression of Alveolar Echinococcosis with Multiorgan Involvement by Use of Recombinant Em18
【24h】

Serological Monitoring of Progression of Alveolar Echinococcosis with Multiorgan Involvement by Use of Recombinant Em18

机译:重组Em18对肺泡棘球cc病多器官侵袭的血清学监测。

获取原文
           

摘要

Two cases of alveolar echinococcosis (AE) with multiple-organ involvement (the liver, lungs, and bone) were monitored by imaging and serology for 20 years. Resection of the bone lesion was complete in one case but incomplete in the other case. Albendazole treatment was markedly to moderately effective against hepatic and pulmonary AE lesions in both cases, whereas it had almost no effect against the bone lesion in one case. The results of the serological tests with recombinant Em18 antigen coincided with the clinical findings in each case. An enzyme-linked immunosorbent assay for the detection of immunoglobulin G (IgG) responses, especially IgG4 responses, is expected to be a real-time indicator of the dynamics of active AE.
机译:通过影像学和血清学监测了2例多器官受累(肺,肺和骨骼)的肺泡棘球co病(AE)。骨病变的切除在一种情况下是完全的,但在另一种情况下是不完全的。在两种情况下,阿苯达唑治疗对肝和肺AE病变均具有明显的中度疗效,而在一种情况下,对骨病变几乎没有作用。在每种情况下,重组Em18抗原的血清学测试结果均与临床发现相符。用于检测免疫球蛋白G(IgG)响应,尤其是IgG4响应的酶联免疫吸附测定有望成为活性AE动态的实时指标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号